-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA Adverse Event Monitoring System Q4 2025 Flags Multiple Potential New Drug Safety Signals, Including Hypersensitivity, Hypogammaglobulinemia, Colitis, Aplastic Anemia And Rhabdomyolysis Under Evaluation

Benzinga·03/31/2026 14:51:03
Listen to the news